Treprostinil

This classification denotes a prostaglandin analogue and antihypertensive agent with the molecular formula C23H34O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RUM6K67ESG, chemically known as u-62,840 but generally known as treprostinil, which bears US NIH Compound Identifier 54786. European Medicines Agency schedules Treprostinil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21168. The term TREPROSTINIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, No. 2, 2003, List 49). World Health Organization schedules treprostinil in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule treprostinil under HS 29375000 and SITC 54156. As of Q4 2014, TREPROSTINIL remains the US FDA Preferred Term for this commodity. Treprostinil bears US NLM identifiers UMLS ID C1145760 and NCI Concept Code C61983. SMILES: OC1C(C2C(C1)Cc1c(C2)cccc1OCC(=O)O)CCC(O)CCCCC.